Upfront autologous stem cell transplantation (ASCT) versus carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation with K maintenance in transplant-eligible, newly diagnosed (NDTE) multiple myeloma (MM).

Kwee Yong, Rakesh Popat, William Wilson et al.|Journal of Clinical Oncology|2021

Cited by 5